Human Metabolome Technologies, Inc. (TYO:6090)

Japan · Delayed Price · Currency is JPY

587.00

-2.00 (-0.34%)

Oct 26, 2026, 3:30 PM JST

Market Cap	3.18B -21.8%
Revenue (ttm)	1.42B -2.3%
Net Income	200.00M -21.9%
EPS	35.64 -18.2%
Shares Out	5.42M
PE Ratio	16.47
Forward PE	n/a
Dividend	18.00 (3.07%)
Ex-Dividend Date	Jun 29, 2026

Volume	700
Open	586.00
Previous Close	589.00
Day's Range	586.00 - 587.00
52-Week Range	570.00 - 766.00
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About TYO:6090

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted panels, flux analysis, and lipidomics services. The company offers solutions for cancer metabolism; metabolic flux analysis; functional food; neurobiology research; renal and disease markers; skin and dermo-metabolomics; T-cell and B-cell metabolism; bacterial, fungal, and algae metabolism; tastan... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2003

Employees 65

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 6090

Full Company Profile

Financial Performance

In fiscal year 2026, TYO:6090's revenue was 1.42 billion, a decrease of -2.34% compared to the previous year's 1.46 billion. Earnings were 200.00 million, a decrease of -21.88%.

Financial Statements